Where it trades today
trading 0% of the way up its 52-week range
How the price has moved
What to weigh before acting
What Matters Now
- The key question is whether steady demand and pricing discipline can protect margins even if growth stays modest.
- CLX trades at 17.3x earnings versus 21.0x for the sector, which means the rerating case depends on proving the discount is too harsh.
- Recent realized volatility is running around 24.4%, above the sector norm of 18.0%, so position sizing matters more than usual.
- CLX remains in a bearish short-term trend and sits 35.5% below its high, which raises the bar for any thesis that depends on fast multiple expansion.
Portfolio Use Case
- CLX is more relevant for investors who want some income support alongside price appreciation, not just pure growth exposure.
- The beta profile suggests it can fit a quality or lower-volatility sleeve more naturally than a high-octane tactical basket.
- This page is most useful for deciding whether the stock deserves a permanent slot in the portfolio or just a place on the watchlist.
What Would Change the View
- A recovery in price alone would not be enough to improve the view; the thesis needs confirmation from improving business or valuation signals.
- Volatility is already above the sector norm, so even a correct long-term thesis can be painful if the position size is too aggressive.
- The view would need revisiting if peers such as PG, KO, PEP start winning the marginal flow or posting cleaner operating momentum.
Methodology
- Price, market cap, beta, yield, and liquidity fields for CLX come from Yahoo Finance quote and summary data.
- 30-day volatility is calculated from recent daily returns and annualized using a 252-trading-day convention.
- Sector context uses stored benchmark averages for Consumer Defensive so each page compares the ticker against a stable peer baseline rather than against the whole market.
- Peer comparisons use the Portfolio Terminal coverage set and highlight nearby listed alternatives such as PG, KO, PEP.
Sources
- Yahoo Finance quote dataopen →
Live quote, valuation, beta, yield, and volume fields used for CLX. Last refresh: Sep 18, 2026, 10:56 PM.
- Portfolio Terminal methodologyopen →
Explains how analytics, refresh cadence, and portfolio interpretation work across the product.
- Peer set and coverage context
Comparative context for this page is anchored around nearby tracked names such as PG, KO, PEP.
What Clorox Company does
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorinda, and Chux brands. It also provides bags and wraps, cat litter, and grilling products under the Glad, Fresh Step, Scoop Away, Kingsford, and Ever…
Employees
9,200
Industry
Household & Personal Products
Headquarters
Oakland, United States
What analysts expect
CLX carries a hold consensus from 17 analysts, with an average price target of $100.76 versus $83.10 today (+21.3%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
CLX generated $6.72B in trailing revenue (-2.0% year over year), with a 8.7% net margin, and $110.38M of free cash flow, against $5.46B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2026 | $6.72B | $2.84B | $886.00M | $587.00M | $4.82 | $405.00M |
| 2025 | $7.10B | $3.21B | $1.18B | $810.00M | — | $761.00M |
| 2024 | $7.09B | $3.05B | $723.00M | $280.00M | $2.26 | $483.00M |
| 2023 | $7.39B | $2.91B | $823.00M | $149.00M | $1.21 | $930.00M |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
How it sits in consumer defensive
Stable sector with essential products like food, beverages, and household goods.
The companies it competes with
CLX beside the consumer defensive names it is usually measured against.
What the chart is saying
Clorox Company trades at $83.10, 35.5% below its 52-week high. With a beta of 0.54, it shows less sensitivity to what the wider market does.
Questions people ask about it
Is CLX a good buy right now?
Clorox Company trades at 17.3x earnings. This is near market average. Current risk level is Medium based on 24.4% volatility.
Does CLX pay dividends?
Yes, Clorox Company offers a dividend yield of 5.88%. That is roughly $4.89 per share a year.
How volatile is CLX?
With 30-day annualized volatility of 24.4% and beta of 0.54, CLX is classified as Medium risk. The stock tends to be more stable than the market average.
What is the analyst price target for CLX?
The average analyst price target for Clorox Company (CLX) is $100.76 based on 17 analyst estimates, about 21.3% above the current price of $83.10. The published range runs from $77.00 to $154.00.
How much revenue does CLX generate?
Clorox Company reported $6.72B in trailing twelve-month revenue. Revenue growth is running at -2.0% year over year. Net margin sits at 8.7%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.